麻豆原创

1. Executive Summary
2. Research Methodology
3. Insulin 麻豆原创
3.1 Background
3.1.1 Cost 鈥� Human & Financial
3.2 Overview
3.3 Insulin Delivery Devices
3.3.1 Vials & Syringes
3.3.2 Insulin Pens
3.3.3 Insulin Pumps
4. 麻豆原创 Analysis
4.1 Insulin 麻豆原创
4.1.1 麻豆原创 Sizing (Actual & Forecasted)
4.1.2 麻豆原创 Share by Insulin Type
4.1.3 麻豆原创 Share by Segment
4.1.4 麻豆原创 Share by Region
4.2 Insulin Delivery Devices
4.2.1 麻豆原创 Sizing (Actual & Forecasted)
4.2.2 麻豆原创 Share by Devices
4.2.3 麻豆原创 Share by End-User
4.2.4 麻豆原创 Share by Region
5. Insulin Delivery Devices 鈥� 麻豆原创 Segmentation
5.1 Vials and Syringes
5.1.1 Overview
5.1.2 麻豆原创 Sizing (Actual & Forecasted)
5.2 Insulin Pens
5.2.1 Overview
5.2.2 麻豆原创 Sizing (Actual & Forecasted)
5.2.3 麻豆原创 Share by End-User
5.3 Insulin Pumps
5.3.1 Overview
5.3.2 麻豆原创 Sizing (Actual & Forecasted)
5.4 Others
6. Regional Analysis
6.1 Europe
6.1.1 Overview
6.1.2 麻豆原创 Sizing (Actual & Forecasted)
6.1.3 Germany
6.1.3.1.1 麻豆原创 Sizing (Actual & Forecasted)
6.2 North America and Caribbean
6.2.1 Overview
6.2.2 麻豆原创 Sizing (Actual & Forecasted)
6.2.3 The US
6.2.3.1.1 麻豆原创 Sizing (Actual & Forecasted)
6.2.3.1.2 麻豆原创 Share by Product
6.3 Asia Pacific
6.3.1 Overview
6.3.2 麻豆原创 Sizing (Actual & Forecasted)
6.3.3 China
6.3.3.1.1 麻豆原创 Sizing (Actual & Forecasted)
7. Pricing Analysis
8. Global Insulin 麻豆原创 Dynamics
8.1 Industry Trends & Developments
8.1.1 Closed-Looped Insulin Delivery/Artificial Pancreas System
8.1.2 Implantable Continuous Glucose Monitoring (CGM) System
8.1.3 Advent of Intelligent Insulin Pens
8.1.4 Next-Generation Insulin Management System Platform
8.2 Growth Drivers
8.2.1 Increasing Incidences of Diabetes
8.2.2 Rise in Geriatric Population
8.2.3 Growing Obese Population
8.2.4 Propagation of Diabetes Management Awareness
8.2.5 Government Impetus
8.3 Challenges
8.3.1 High Cost of Insulin Pumps
8.3.2 Insurance Coverage issue
8.3.3 Regulatory Pressure
8.3.4 Technological Issue
9. Competitive Landscape
9.1 Insulin 麻豆原创
9.2 Insulin Delivery Devices
9.2.1 Insulin Delivery Devices 麻豆原创
9.2.2 Insulin Pens 麻豆原创
9.2.3 Insulin Pumps 麻豆原创
10. Company Profiles
10.1 Novo Nordisk
10.2 Sanofi Aventis
10.3 Eli Lilly and Company
10.4 Merck & Co.

List of Tables
Table 1: Comparison of Various Insulin Delivery Methods
Table 2: Insulin and Diabetes Drugs Approved Between 2012-2018
Table 3: Worldwide Sales of Various Types of Insulin, 2018 (US$ Billions)
Table 4: Top Insulin Pump Comparisons
Table 5: Comparison of Insulin Pumps and Insulin Pens
Table 6: Europe Diabetes Statistics
Table 7: North America Diabetes Statistics
Table 8: Asia Pacific Diabetes Statistics
Table 9: China Diabetes Statistics
Table 10: Proportion of Undiagnosed Diabetic Population Aged (20-79 years), 2018E
Table 11: Coverage of Popular Insulin Drug Brands
Table 12: Novo Nordisk 鈥� Diabetes R&D Pipeline
Table 13: Sanofi Aventis Diabetes Pipeline
Table 14: Eli Lilly and Company Clinical Development Pipeline
Table 15: Merck & Co. Product Pipeline

List of Figures
Figure 1: Rockville Research 鈥� Research Methodology
Figure 2: Top ten countries/territories for Number of Adults with Diabetes (Million)
Figure 3: Global Diabetes Healthcare Expenditure and Treatment Cost per Patient, 2017 (US$ Billion)
Figure 4: Global Diabetes Care 麻豆原创 by Treatment Class, 2011-18E (US$ Millions)
Figure 5: Block Diagram Representation of Insulin Regulation in Body
Figure 6: Insulin Production and Action
Figure 7: Global Insulin 麻豆原创 Size by Value, 2011-18E (US$ Billions)
Figure 8: Global Insulin 麻豆原创 Size by Value Forecasted, 2019E-24E (US$ Billions)
Figure 9: Global Insulin 麻豆原创 Share by Type (2018E)
Figure 10: Global Insulin 麻豆原创 (Volume) Share by Segment (2018E)
Figure 11: Global Insulin 麻豆原创 (Volume) Share by Region (2018E)
Figure 12: Global Insulin Delivery Devices 麻豆原创 Size by Value, 2014-24E (US$ Billions)
Figure 13: Global Insulin Delivery Devices 麻豆原创 Share by Product, 2014-24E (%)
Figure 14: Global Insulin Delivery Devices 麻豆原创 Share by End-User, 2018E & 2024E (US$ Million)
Figure 15: Insulin Delivery Devices 麻豆原创 Share by Region (2018E)
Figure 16: Global Insulin Syringes 麻豆原创 Size by Value, 2014-24E (US$ Billions)
Figure 17: Global Insulin Injectors 麻豆原创 Size by Value, 2014-24E (US$ Billions)
Figure 18: Global Insulin Pens 麻豆原创 Size by Value, 2014-24E (US$ Billions)
Figure 19: Global Insulin Pens 麻豆原创 Share by End-User (2018E)
Figure 20: Global Insulin Pumps 麻豆原创 Size by Value, 2014-24E (US$ Billions)
Figure 21: Europe - Insulin 麻豆原创 Size by Value, 2014-24E (US$ Billions)
Figure 22: Europe Insulin Delivery Devices 麻豆原创 Size by Value, 2014-24E (US$ Billions)
Figure 23: Germany Insulin Delivery Devices 麻豆原创 Size by Value, 2017-24E (US$ Billions)
Figure 24: North America - Insulin 麻豆原创 Size by Value, 2014-24E (US$ Billions)
Figure 25: North America - Insulin Delivery Devices 麻豆原创 Size by Value, 2014-24E (US$ Billions)
Figure 26: The US - Insulin 麻豆原创 Size by Value, 2014-24E (US$ Billion)
Figure 27: The US Insulin Delivery Devices 麻豆原创 Size by Value, 2017-24E (US$ Billions)
Figure 28: The US Insulin Delivery Devices 麻豆原创 Share by Product, 2014-24E (%)
Figure 29: Asia Pacific - Insulin 麻豆原创 Size by Value, 2014-24E (US$ Billions)
Figure 30: Asia Pacific Insulin Delivery Devices 麻豆原创 Size by value, 2014-24E (US$ Billions)
Figure 31: China - Insulin 麻豆原创 Size by Value, 2014-24E (US$ Billion)
Figure 32: China Insulin Delivery Devices 麻豆原创 Size by Value, 2017-24E (US$ Billions)
Table 10: Prices of Popular Insulins
Figure 33: Cost of Insulin, Jul鈥�1996 鈥� Jul鈥�2016
Figure 34: Worldwide Insulin Cost Increment, 2005 vs. 2015
Figure 35: Worldwide Insulin Price Comparison, Cost per vial of Insulin (Feb鈥�2016)
Figure 36: Intelligent Insulin Pens Connectivity Options
Figure 36: Next-Generation Insulin Management System Platform
Figure 37: Worldwide Diabetes Incidence by Region, 2015 & 2040E (Millions)
Figure 38: Prevalence of People with Diabetes by Age and Sex, 2015
Figure 39: Global Obese Population 2012-18E (Millions)
Figure 40: Global Diabetes Care 麻豆原创 (Value) Share by Competitors (2018E)
Figure 41: Global Modern Insulin Volume 麻豆原创 Share by Competitors (2018E)
Figure 42: Global Basal Insulin 麻豆原创 Share by Drug Brands (2018E)
Figure 43: Global Rapid-Action Insulin 麻豆原创 Share by Drug Brands (2018E)
Figure 44: Global Insulin Delivery Devices 麻豆原创 Share by Competitors (2018E)
Figure 45: Global Insulin Pens 麻豆原创 Share by Competitors (2018E)
Figure 46: Global Smart Insulin Pens 麻豆原创 Share by Competitors (2018E)
Figure 47: Global Insulin Pumps 麻豆原创 Share by Companies (2018E)
Figure 48: Global Disposable Insulin Pumps 麻豆原创 Share by Companies (2018E)
Figure 49: Novo Nordisk Diabetes and Obesity Care Sales by Segment, FY2012-FY2017 (US$ Billion)
Figure 50: Sanofi Aventis Net Sales, FY2012-FY2017 (US$ Billion)
Figure 51: Eli Lilly and Company Net Sales, FY2012-FY2017 (US$ Billion)
Figure 52: Merck & Co. Revenue by Business Segment (FY2017)
Figure 53: Merck & Co. Net Sales, FY2012-FY2017 (US$ Billion)